...Welcome To The Resverlogix HUB On AGORACOM!

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial (now fully enrolled) and Will Soon Begin Phase 2 Kidney Dialysis and Fabry Disease Trials**

Message: Isreal Deal

"total royalty payments are estimated to potentially reach in excess of US$100 million...."

What an ugly way to phrase something.....it could have been stated a much clearer manner, like

"total royalty payents could exceed $100 million"  

New Message
Please login to post a reply